Body fat distribution is now recognized as an important predictor of t
he adverse health consequences of obesity, Upper body obesity, especia
lly with increasing visceral fat, is associated with hypertension, ins
ulin resistance, dyslipidemia, type II diabetes mellitus and premature
coronary death, Several lines of evidence suggest that abnormal adipo
se tissue lipolysis, resulting in elevated free fatty acid (FFA) avail
ability, may contribute to some of the metabolic consequences of upper
body obesity. The vast majority of the elevated systemic FFA release
appears to come from upper body, non-splanchnic adipose tissue. Thus,
dysregulation of upper body, non-splanchnic adipose tissue lipolysis m
ay play an important role in contributing to health consequences of fa
t distribution.